$Moderna(MRNA.US) rose slightly, while $Pfizer(PFE.US), $Unitedhealth(UNH.US), $WUXI BIO(02269.HK), and $WUXI APPTEC(02359.HK) all fell. Major pharmaceutical companies and this batch of CXO stocks were under overall pressure. $Moderna(MRNA.US) bucked the trend and turned green due to expectations of a pre-flu season recovery driven by mRNA technology, being the only slightly pleasant surprise in this batch. $Pfizer(PFE.US) was weighed down by healthcare policy and pipeline sentiment, $Unitedhealth(UNH.US) continued to digest policy concerns, while the two CXO companies, $WUXI BIO(02269.HK) and $WUXI APPTEC(02359.HK), weakened along with Hong Kong stock market sentiment 😔. Within the biopharmaceutical sector today, the situation was one where large-cap stocks held up against the decline, while CXO and policy-sensitive stocks remained relatively soft.